Exploratory studies with NX-13: oral toxicity and pharmacokinetics in rodents of an orally active, gut-restricted first-in-class therapeutic for IBD that targets NLRX1-Reference-Cited by-同舟云学术

Exploratory studies with NX-13: oral toxicity and pharmacokinetics in rodents of an orally active, gut-restricted first-in-class therapeutic for IBD that targets NLRX1

Published:2019-10-25 Issue:1 Volume:45 Page:209-214
ISSN:0148-0545
Container-title:Drug and Chemical Toxicology
language:en
Short-container-title:Drug and Chemical Toxicology

Author:

Leber Andrew¹²,Hontecillas Raquel¹²,Zoccoli-Rodriguez Victoria¹,Ehrich Marion³,Chauhan Jyoti¹,Bassaganya-Riera Josep¹²^ORCID

Affiliation:

1. Landos Biopharma Inc, Blacksburg, VA, USA

2. BioTherapeutics Inc, Blacksburg, VA, USA

3. Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, VA, USA

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01480545.2019.1679828

Reference19 articles.

1. Pancréatite récurrente révélant une maladie de Crohn

2. Exploratory Studies With BT-11

3. Skin signs of gastrointestinal disease1 1Abbreviations used in this paper: AVM, arteriovenous fistulae and malformations; HHT, hereditary hemorrhagic telangiectasia.

4. GI clinical research 2002–2003: the year in review

5. Non-Systemic Drugs: A Critical Review

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on negatively regulated NLRs in inflammation and cancer;International Immunopharmacology;2024-07

2. NLRX1: Versatile functions of a mitochondrial NLR protein that controls mitophagy;Biomedical Journal;2024-02

3. The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study;Journal of Crohn's and Colitis;2023-11-11

4. Mitochondria in innate immunity signaling and its therapeutic implications in autoimmune diseases;Frontiers in Immunology;2023-04-12

5. Trust Your Gut: Strategies and Tactics for Intestinally Restricted Drugs;ACS Medicinal Chemistry Letters;2023-02-22